Dr. John Adamson, MD

NPI: 1477504801
Total Payments
$15,759
2024 Payments
$122.73
Companies
12
Transactions
28
Medicare Patients
256
Medicare Billing
$30,214

Payment Breakdown by Category

Other$8,495 (53.9%)
Consulting$3,125 (19.8%)
Travel$2,429 (15.4%)
Food & Beverage$1,708 (10.8%)
Education$2.14 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,115 1 32.5%
Honoraria $3,380 1 21.4%
Consulting Fee $3,125 1 19.8%
Travel and Lodging $2,429 7 15.4%
Food and Beverage $1,708 17 10.8%
Education $2.14 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Daiichi Sankyo Inc. $5,735 4 $0 (2017)
Celgene Corporation $4,567 6 $0 (2017)
CSL Behring $4,278 4 $0 (2017)
Alexion Pharmaceuticals, Inc. $491.16 5 $0 (2019)
Genentech USA, Inc. $168.17 2 $0 (2019)
PORTOLA PHARMACEUTICALS, INC. $124.91 1 $0 (2019)
SOBI, INC $122.73 1 $0 (2024)
Rigel Pharmaceuticals, Inc. $120.96 1 $0 (2019)
Bioverativ Therapeutics Inc. $52.55 1 $0 (2017)
Novo Nordisk Health Care AG $40.50 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $122.73 1 SOBI, INC ($122.73)
2023 $21.55 1 Novo Nordisk Inc ($21.55)
2021 $40.50 1 Novo Nordisk Health Care AG ($40.50)
2019 $477.36 4 PORTOLA PHARMACEUTICALS, INC. ($124.91)
2018 $58.52 1 Genentech USA, Inc. ($58.52)
2017 $15,038 20 Daiichi Sankyo Inc. ($5,735)

All Payment Transactions

28 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
09/14/2024 SOBI, INC DOPTELET (Drug) Food and Beverage In-kind items and services $122.73 General
Category: HEMATOLOGY/ONCOLOGY
06/15/2023 Novo Nordisk Inc Novoeight (Drug), Rebinyn, Tretten Food and Beverage In-kind items and services $21.55 General
Category: Hemophilia
11/16/2021 Novo Nordisk Health Care AG Food and Beverage In-kind items and services $40.50 General
05/22/2019 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $121.84 General
05/10/2019 Genentech USA, Inc. HEMLIBRA (Biological) Food and Beverage In-kind items and services $109.65 General
Category: Hematology
05/02/2019 PORTOLA PHARMACEUTICALS, INC. ANDEXXA (Biological) Food and Beverage In-kind items and services $124.91 General
Category: HEMATOLOGY/NEUROLOGY
03/14/2019 Rigel Pharmaceuticals, Inc. Tavalisse (Drug) Food and Beverage In-kind items and services $120.96 General
Category: Hematology
11/28/2018 Genentech USA, Inc. Food and Beverage In-kind items and services $58.52 General
12/11/2017 Bioverativ Therapeutics Inc. Food and Beverage In-kind items and services $52.55 General
10/16/2017 Celgene Corporation Sotatercept (Drug) Consulting Fee Cash or cash equivalent $3,125.00 General
10/12/2017 Celgene Corporation Sotatercept (Drug) Travel and Lodging In-kind items and services $742.40 General
10/12/2017 Celgene Corporation Sotatercept (Drug) Travel and Lodging In-kind items and services $251.58 General
10/12/2017 Celgene Corporation Sotatercept (Drug) Travel and Lodging In-kind items and services $250.00 General
10/12/2017 Celgene Corporation Sotatercept (Drug) Food and Beverage In-kind items and services $123.10 General
10/12/2017 Celgene Corporation Sotatercept (Drug) Travel and Lodging Cash or cash equivalent $75.00 General
08/28/2017 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $123.60 General
Category: Immunology
05/06/2017 CSL Behring Afstyla (Biological) Honoraria Cash or cash equivalent $3,380.00 General
Category: Hemophilia
05/05/2017 CSL Behring Afstyla (Biological) Travel and Lodging In-kind items and services $564.72 General
Category: Hemophilia
05/05/2017 CSL Behring Afstyla (Biological) Food and Beverage In-kind items and services $287.03 General
Category: Hemophilia
04/07/2017 CSL Behring Afstyla (Biological) Food and Beverage In-kind items and services $45.87 General
Category: Hemophilia
04/07/2017 PFIZER INC. BENEFIX (Biological) Food and Beverage In-kind items and services $35.98 General
Category: HEMATOLOGY
03/20/2017 Daiichi Sankyo Inc. INJECTAFER (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,115.00 General
Category: Anemia
03/07/2017 Daiichi Sankyo Inc. INJECTAFER (Drug) Travel and Lodging In-kind items and services $356.25 General
Category: Anemia
03/07/2017 Daiichi Sankyo Inc. INJECTAFER (Drug) Travel and Lodging In-kind items and services $188.91 General
Category: Anemia
03/07/2017 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $75.21 General
Category: Anemia

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 86 99 $33,387 $8,811
2022 3 79 102 $39,728 $9,783
2021 2 47 55 $21,819 $6,667
2020 2 44 53 $20,002 $4,953
Total Patients
256
Total Services
309
Medicare Billing
$30,214
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 43 55 $20,295 $5,517 27.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 25 26 $6,630 $1,757 26.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 18 18 $6,462 $1,538 23.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 47 67 $24,723 $6,353 25.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 20 20 $11,180 $2,544 22.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 12 15 $3,825 $885.46 23.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 29 36 $12,724 $3,706 29.1%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 18 19 $9,095 $2,961 32.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 27 33 $11,022 $2,663 24.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 17 20 $8,980 $2,290 25.5%

About Dr. John Adamson, MD

Dr. John Adamson, MD is a Hematology healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477504801.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Adamson, MD has received a total of $15,759 in payments from pharmaceutical and medical device companies, with $122.73 received in 2024. These payments were reported across 28 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($5,115).

As a Medicare-enrolled provider, Adamson has provided services to 256 Medicare beneficiaries, totaling 309 services with total Medicare billing of $30,214. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Hematology
  • Location San Diego, CA
  • Active Since 05/12/2006
  • Last Updated 11/12/2025
  • Taxonomy Code 207RH0000X
  • Entity Type Individual
  • NPI Number 1477504801

Products in Payments

  • INJECTAFER (Drug) $5,735
  • Sotatercept (Drug) $4,567
  • Afstyla (Biological) $4,278
  • SOLIRIS (Drug) $367.18
  • ANDEXXA (Biological) $124.91
  • DOPTELET (Drug) $122.73
  • Tavalisse (Drug) $120.96
  • HEMLIBRA (Biological) $109.65
  • BENEFIX (Biological) $35.98
  • Novoeight (Drug) $21.55
  • Strensiq (Drug) $2.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Hematology Doctors in San Diego